wherein R 1 represents alkyl, R 2 represents alkyl or mono-, bi- or tricycloalkyl, R 3 represents an optionally substituted phenyl, naphthyl or heterocyclyl group, and Z represents oxygen or sulphur, and when said heterocyclyl groups contain one or more nitrogen ring atoms, N-oxides thereof, and pharmaceutically acceptable salts thereof, possess useful pharmacological properties.
摘要:
An inhaler for powdered medicament in capsules has a swirling chamber which can be opened to allow access of a closed capsule into the swirling chamber for operation of capsule-opening means in the swirling chamber. Access to the swirling chamber is gained by a pivoting cover member (22) which is provided with interlock means associated with the capsule-opening means to ensure that the capsule opening means cannot be operated while the cover member is in its open position to allow access of the user's fingers to the region (28) of the swirling chamber (26,28) where the capsule-opening pins (30) could damage the user's finger.
摘要:
Therapeutically useful thioformamide derivatives of the formula: wherein R represents alkyl, Het represents pyrid-3-yl, isoquinolin-4-yl, tetrahydroquinolin-3-yl, quinolin-3-yl, pyridazin-4-yl, pyrimid-5-yl, thiazol-5-yl, thieno[2,3-b]pyridin-5-yl, pyrazin-2-yl, indol-3-yl and thieno[3,2-b]pyridin-6-yl, Y represents ethylene, methylene or a valency bond, and X represents carbonyl, hydroxymethylene, >C=NOR¹, >C=NN(R¹)₂ or >C=NN(R¹)CON(R¹)₂ in which R¹ represents hydrogen or optionally substituted alkyl, benzyl, phenethyl, 1-naphthylmethyl, 2-naphthylmethyl or pyrid-3-ylmethyl, or two R¹ substituents on the same nitrogen atom may together form an optionally substituted alkylene radical chain and salts thereof, processes for their preparation and compositions containing them are described.
摘要:
This invention is directed to physiologically active compounds of formula (I) wherein (i) represents a bicyclic ring system, of about 10 to about 13 ring members, in which the ring (ii) is an azaheterocycle, and the ring (iii) represents an azaheteroaryl ring, or an optionally halo substituted benzene ring; wherein R?1-R3, A1, Z1¿, m and n are as defined herein. Such compounds inhibit the production or physiological effects of TNF and inhibit cyclic AMP phosphodiesterase. The invention is also directed to pharmaceutical compositions comprising compounds of formula (I), their pharmaceutical use and methods for their preparation.
摘要:
An inhaler for inhaling pulverulent medicament from within a capsule comprises a chamber (24) within which the capsule is positioned with its longitudinal axis in the median plane of the chamber and thus generally parallel to the front (29) and rear walls (30) of the chamber, where the spacing between said front and rear walls is just greater than the diameter of the capsule and the diameter of the chamber is larger than the capsule's length. The device includes pins (21) serving as opening means to pierce the ends of the capsule while it is seated in a recess (25). Air inlets (26), chamber (24) and mouthpiece (27) are in such a spatial relation as to create a swirling or vortexing movement of the airflow which allows good capsule's emptying and powders to be finely dispersed. Chamber and mouthpiece inner walls can be of antistatic material.
摘要:
An inhaler for inhaling pulverulent medicament from within a capsule comprises a chamber 24 within which the capsule is free to rotate while having its longitudinal axis in the median plane of the chamber and thus generally parallel to the front and rear walls 29 and 30 of the chamber, by virtue of the fact that the spacing between said front and rear walls is less than the axial length of the capsule but just greater than the diameter of the capsule. The device includes pins 21 serving as opening means to pierce the ends of the capsule while it is seated in a recess 25, whereupon the retraction of the pins 21 allows the capsule to be entrained into swirling airflow in the chamber 24 during inhalation of air through air inlets 26 and out through a mouthpiece nozzle 27.
摘要:
A process is described for the preparation of a compound of formula (I) or a stereoisomeric compound thereof, in which the 1,2-position is saturated or is a double bond; X?1 and X2¿ are each independently hydrogen or halogen; R1 is hydrogen or acyl; R2 is hydroxyl, acyloxy or oxo; and R3 is alkyl, by reacting a compound of formula (II) with an aldehyde R3CHO in either phosphoric acid or about 60 % to about 75 % w/w sulphuric acid. Compounds of formula (I) are either pharmacologically active steroids or are intermediates in the synthesis of pharmacologically active steroids.
摘要:
Steroids of formula (I) where -^_-^_-^_-^_ is independently at each of the 1,2-, 4,5- and 6,7-positions, a single or double bond; R1 is a straight- or branched-chain C1-4 alkyl or C2-4 alkenyl; R2 is hydrogen or methyl; R3 is C1-7 alkyl, phenyl, substituted phenyl, heteroaryl, substituted heteroaryl or -CH2R where R is halo, hydroxy, C1-5 alkoxy or C1-10 alkanoyloxy; R4 is hydrogen, halo, hydroxy, keto or C1-3 alkoxy when -^_-^_-^_-^_ at the 6,7-position forms a single bond, or hydrogen, halo or C1-3 alkoxy when -^_-^_-^_-^_ at the 6,7-position forms a double bond; R5 is hydrogen or halo; R6 is hydrogen when -^_-^_-^_-^_ at the 1,2-position forms a single bond or hydrogen or chloro when -^_-^_-^_-^_ at the 1,2-position forms a double bond; and n is 0-2; and racemic mixtures and diastereoisomers thereof, processes for their preparation, pharmaceutical compositions containing them, and methods for their use, especially as antiinflammatories.
摘要:
This invention relates to an abuse resistant tablet containing two or more layers comprising one or more drugs and one or more gelling agents wherein the drug(s) and gelling agent(s) are contained in separate layers of the tablet. The multilayer tablet is particularly suitable for the administration of drugs prone to abuse by unauthorised parenteral administration such as analgesics, hypnotics and anxiolytics.
摘要:
A process is described for the preparation of a compound of formula (IX) from 4-hydroxybutyl 3-pyridyl ketone. The compound of formula (IX) is an intermediate useful in the preparation of (1R,2R)-2-(3-pyridyl)-N-alkyl-tetrahydro-2H-thiopyran-2-carbothioamide 1-oxides which possess useful pharmaceutical properties, for example anti-hypertensive properties.